|1 Table of Contents 3
|1.1 List of Tables 6
|1.2 List of Figures 6
2 Introduction 8
2.1 What Is This Report About? 8
2.2 Drug Delivery Devices Market Segmentation 8
2.3 Definitions of Markets Covered in the Report 9
3 Drug Delivery Devices Market, India 11
3.1 Drug Delivery Devices Market, India, Revenue ($m), 2018-2033 11
3.2 Drug Delivery Devices Market, India, Revenue Mix ($m), 2023 12
3.3 Drug Delivery Devices Market, India, Category Contribution by Revenue ($m), 2023 13
3.4 Drug Delivery Devices Market, India, Revenue ($m), 2018-2033 14
3.5 Drug Delivery Devices Market, India, Volume (Units), 2018-2033 16
3.6 Drug Delivery Devices Market, India, Volume (Units), 2018-2033 17
3.7 Drug Delivery Devices Market, India, Company Share by Revenue ($m), 2023 19
4 Central Venous Catheters Market, India 21
4.1 Central Venous Catheters Market, India, Revenue Mix ($m), 2023 21
4.2 Central Venous Catheters Market, India, Segment Contribution (%), 2023 22
4.3 Central Venous Catheters Market, India, Revenue ($m), 2018-2033 23
4.4 Central Venous Catheters Market, India, Volume (Units), 2018-2033 25
4.5 Central Venous Catheters Market, India, Average Price ($), 2018-2033 27
4.6 Central Venous Catheters Market, India, Distribution Share by Revenue ($m), 2023 28
4.7 Central Venous Catheters Market, India, Company Share by Revenue ($m), 2023 29
5 Implantable Ports Market, India 31
5.1 Implantable Ports Market, India, Revenue Mix ($m), 2023 31
5.2 Implantable Ports Market, India, Segment Contribution (%), 2023 32
5.3 Implantable Ports Market, India, Revenue ($m), 2018-2033 33
5.4 Implantable Ports Market, India, Volume (Units), 2018-2033 35
5.5 Implantable Ports Market, India, Average Price ($), 2018-2033 37
5.6 Implantable Ports Market, India, Distribution Share by Revenue ($m), 2023 38
5.7 Implantable Ports Market, India, Company Share by Revenue ($m), 2023 39
6 Infusion Systems Market, India 40
6.1 Infusion Systems Market, India, Revenue Mix ($m), 2023 40
6.2 Infusion Systems Market, India, Segment Contribution (%), 2023 41
6.3 Infusion Systems Market, India, Revenue ($m), 2018-2033 42
6.3.1 Infusion Pump Disposables Market, India, Revenue ($m), by Segment, 2018-2033 44
6.3.2 Infusion Pumps Market, India, Revenue ($m), by Segment, 2018-2033 46
6.4 Infusion Systems Market, India, Volume (Units), 2018-2033 48
6.4.1 Infusion Pump Disposables Market, India, Volume (Units), by Segment, 2018-2033 50
6.4.2 Infusion Pumps Market, India, Volume (Units), by Segment, 2018-2033 52
6.5 Infusion Systems Market, India, Average Price ($), 2018-2033 54
6.6 Infusion Systems Market, India, Distribution Share by Revenue ($m), 2023 55
6.7 Infusion Systems Market, India, Company Share by Revenue ($m), 2023 56
7 Overview of Key Companies in India, Drug Delivery Devices Market 57
7.1 Becton Dickinson and Co 57
7.1.1 Company Overview 57
7.2 B. Braun Melsungen AG 57
7.2.1 Company Overview 57
7.3 Teleflex Inc 57
7.3.1 Company Overview 57
7.4 Baxter International Inc 57
7.4.1 Company Overview 57
8 Drug Delivery Devices Market Pipeline Products 58
9 Financial Deals Landscape 66
9.1 Acquisition 66
9.1.1 Torrent Investments Sells
2.9% Stake in Torrent Pharmaceuticals for USD366.92 Million 66
9.1.2 Cipla and Alkem Laboratories may Acquire Majority Stake in Sahajanand Medical Technologies 67
9.1.3 Consortium of Investors to Acquires 26% Stake in Raymed Labs for USD
0.03 Million 68
9.1.4 Eris Lifesciences to Acquire 100% Stake in Chemman Labs For USD12.54 Million 69
9.2 Equity Offerings 70
9.2.1 Poly Medicure Raises USD1.19 Billion in Private Placement of Shares 70
9.2.2 Morepen Laboratories Raises USD23.86 Million in Qualified Institutional Placement of Shares 72
9.2.3 Torrent Pharma Plans to Raise USD600.5 Million in Private Placement of Shares 75
9.3 Partnerships 76
9.3.1 Aptar Pharma India Enters into Co-Development Agreement with Pulmotree Medical 76
9.3.2 Nestle India to Form Joint Venture With Dr. Reddy’s 77
9.4 Private Equity 79
9.4.1 Platinum Equity Advisors Acquires Majority Stake in Inventia Healthcare from InvAscent Capital and Jacob Ballas Capital India 79
9.4.2 Maiva Pharma Raises USD119.8 Million in Private Financing 81
10 Recent Developments 83
10.1 Corporate Communications 83
10.1.1 Mar 11, 2025: Poly Medicure Receives MDR Certification for 54 Products, Strengthening Its Leadership in Medical Device Industry 83
10.1.2 Feb 21, 2025: Noris Medical Receives FDA 510(k) Clearance for LONGY-N Implant 83
10.1.3 Feb 01, 2025: Lupin Announces Closure of Inspection by U.S. FDA at its Somerset Facility with No Observations 83
10.1.4 Sep 02, 2024: Mr. Adil Zainulbhai and Mr. Ashok Sinha Are Completing Their Second Term as an Independent Director on 2nd September 2024 83
10.1.5 Aug 12, 2024: Raymed Labs: Notice of 32nd Annual General Meeting 84
10.1.6 Jul 23, 2024: Torrent Pharmaceuticals : Change in Senior Management Personnel 84
10.1.7 Jun 25, 2024: Closure of US FDA Inspection at Company’s Manufacturing Facility Located at Baddi, India 84
10.1.8 May 07, 2024: Dr. Reddy's Laboratories Announces Dividend and Annual General Meeting 84
10.2 Financial Announcements 85
10.2.1 Nov 11, 2024: Morepen Laboratories Announces Consolidated Financial Results for the and Half Year Ended 30th September 2024 85
10.2.2 Aug 14, 2024: Solasia Pharma Reports Financial Results for the Second Quarter of the Fiscal Year Ending December 31, 2024 85
10.2.3 Aug 14, 2024: Glenmark Pharma Reports Consolidated Revenue Growth of
6.9%, EBITDA Margin of
18.1% and PAT Margin of
10.5% YoY for Q1 FY 2024-25 85
10.2.4 Aug 01, 2024: Sun Pharmaceutical Industries Announces Results for Quarter Ended June 30, 2024 86
10.2.5 Jul 16, 2024: Sun Pharma to Announce First Quarter Results on August 01, 2024 86
10.3 Other Significant Developments 86
10.3.1 Sep 30, 2024: Lupin and Scope Sign a Distribution Agreement for the Commercialization of Optase Range of Products in Mexico 86
10.4 Product News 87
10.4.1 Oct 28, 2024: Lupin to focus on the Lupin to Focus on the Development of Inhalers with Near-Zero Global Warming Potential Propellantsof inhalers with near-zero global warming potential propellants 87
11 Appendix 88
11.1 Research Methodology 89
11.1.1 Coverage 89
11.1.2 Secondary Research 89
11.1.3 Primary Research 90
11.1.4 Market Modeling and Forecasting 91
11.1.5 Company Share Analysis 92
11.1.6 Distribution Share Analysis 92
11.1.7 Benchmarking 93
11.2 GlobalData Consulting 93
11.3 Contact Us 93
11.4 Disclaimer 94